Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsOn World Oxygen Day, the COPD Foundation's Mike Hess outlines the stigma, training gaps, and Medicare barriers affecting patients on supplemental oxygen.
Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.
A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.
Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT
Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD
A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.
Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.
1.
An inadvertent loss of weight may be an indication to consult a physician, according to research.
2.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
3.
Hereditary cancer has a rare and underreported cause.
4.
Combo Therapy Boosts Early CML Response but Not Long Term
5.
Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice
1.
Exposure Modeling for Bispecific Antibodies: Scientific Foundations and Clinical Implications
2.
Screening for Functional and Social Vulnerability in Long-Term Cancer Survivors
3.
Robotic Intratumoral Resection for Organ Preservation: Advances, Evidence, and Clinical Implications
4.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
5.
Comprehensive Standards in Oncology for Modern Medicine
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
5.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge